+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Improved long-term graft outcome in lung transplant recipients who have donor antigen-specific hyporeactivity



Improved long-term graft outcome in lung transplant recipients who have donor antigen-specific hyporeactivity



Journal of Heart and Lung Transplantation 13(1 Pt 1): 30-6; Discussion 36-7



We have shown that in renal transplant recipients the development of in vitro donor antigen-specific hyporeactivity correlates with improved long-term graft outcome. Donor antigen-specific hyporeactivity is determined by in vitro mixed lymphocyte culture assays with recipient cells used as responder cells and homozygous typing cells as stimulator cells. Hyporeactivity is defined as a decreased response to stimulation by specific homozygous typing cells that define donor antigens, whereas response to homozygous typing cells defining third-party antigens remains unchanged. We tested 23 lung transplant recipients at least 1 year after transplantation to determine if donor antigen-specific hyporeactivity and the corresponding improved graft outcome were organ specific. Of these 23 recipients, eight had donor antigen-specific hyporeactivity; they demonstrated a trend toward a lower incidence of late acute rejection episodes (one rejection episode in one patient) versus the 15 recipients who remained responsive to donor antigens (11 rejection episodes in six patients). No recipients with donor antigen-specific hyporeactivity have been diagnosed with obliterative bronchiolitis, unlike six recipients who remained responsive to donor antigens (0% versus 40%; p = 0.058). We conclude that immune regulation, as evidenced by donor antigen-specific hyporeactivity, correlates with improved graft outcome for lung transplant recipients and may even provide immunologically based criteria for selecting candidates whose immunosuppression might be reduced successfully.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 008831161

Download citation: RISBibTeXText

PMID: 7513186


Related references

Improved long-term graft function in kidney transplant recipients with donor antigen-specific hyporeactivity. Pediatric Transplantation 11(2): 139-144, 2007

Persistence of donor antigen and donor antigen-specific hyporeactivity predict long-term lung transplant success. Journal of Heart & Lung Transplantation 13(1 Part 2): S54, 1994

Allogeneic microchimerism and donor antigen-specific hyporeactivity in lung transplant recipients. Clinical Transplantation 9(6): 442-449, 1995

Organ-specific patterns of donor antigen-specific hyporeactivity and peripheral blood allogeneic microchimerism in lung, kidney, and liver transplant recipients. Transplantation 60(12): 1546-1554, 1995

Evidence that improved late renal transplant outcome correlates with the development of in vitro donor antigen-specific hyporeactivity. Transplantation 55(5): 1017-1023, 1993

Donor-specific hyporeactivity in lung transplant recipients. Immunology Letters 56(Part-P1): 150-0, 1997

Improved long term graft survival in pediatric donor kidney transplant recipients using quadruple immunosuppression. Journal of Urology 149(4 Suppl. ): 390A, 1993

Correlation of donor antigen-specific hyporeactivity with allogeneic microchimerism in kidney and lung recipients. Pediatric Nephrology. 9(Suppl.): S35-S39, 1995

Long-Term Persistence of Donor Alveolar Macrophages in Human Lung Transplant Recipients That Influences Donor-Specific Immune Responses. American Journal of Transplantation 16(8): 2300-2311, 2016

Organ-Specific Patterns Of Donor Antigen-Specific Hyporeactivity And Peripheral Blood Allogeneic Microchimerism In Lung, Kidney, And Liver Transplant Recipients1. Transplantation 60(12): 1546-1554, 1995

Long-term evaluation of proliferative donor antigen-specific reactivity in cadaveric kidney transplant recipients. Transplant International 13(3): 187-193, 2000

Improved Long-Term Survival in Kidney Transplant Recipients with Donor-Specific HLA Antibodies After Mycophenolic Acid Escalation. Clinical Transplants 2014: 137-142, 2014

Prophylactic use of deoxyspergualin improves long-term graft survival in living related renal transplant recipients transfused with donor-specific blood. Transplantation Proceedings 33(3): 2256-2257, 2001

Donor antigen-specific hyporeactivity and peripheral blood allogeneic microchimerism as predictors of a chronic rejection-free state in lung and heart recipients. Journal of Heart & Lung Transplantation 16(1): 82, 1997

Deoxyspergualin prophylaxis with tacrolimus further improves long-term graft survival in living-related renal-transplant recipients transfused with donor-specific blood. Transplantation Proceedings 37(2): 927-929, 2005